Parallel Advisors, LLC Axogen, Inc. Transaction History

Parallel Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 20, 2024	BUY	$7.53 - $10.95 $753 - $1,095	100 New	100 $0
Q3 2022 Nov 10, 2022	BUY	$8.14 - $12.25 $814 - $1,225	100 New	100 $1,000
Q4 2020 Feb 02, 2021	SELL	$11.5 - $17.96 $34,523 - $53,915	-3,002 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$12.09 - $20.46 $35,919 - $60,786	2,971 Added 9583.87%	3,002 $37,000
Q1 2019 May 01, 2019	BUY	$14.62 - $22.13 $453 - $686	31 New	31 $1,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.